Taro

$75.64
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.19 (+1.60%) Today

$0.00 (0.00%) As of 8:00 PM UTC after-hours

Why Robinhood?

You can buy or sell Taro and other stocks, options, and ETFs commission-free!

About TARO

Taro Pharmaceutical Industries Ltd. engages in the development, manufacturing and marketing of prescribed and over-the-counter pharmaceutical products in the U.S., Canada and Israel. Its products include semi-solids formulations, such as creams and ointments and other dosage forms such as liquids, capsules and tablets, in the dermatological and topical, cardiovascular, neuropsychiatric and anti-inflammatory therapeutic categories.

CEO

Uday Vijaykumar Baldota

Employees

1,464

Headquarters

Haifa Bay, Haifa

Founded

1950

Market Cap

2.89B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

32.01K

High Today

$76.00

Low Today

$74.64

Open Price

$75.00

Volume

26.36K

52 Week High

$80.00

52 Week Low

$53.95

TARO Earnings

$0.00

$0.59

$1.17

$1.76

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Estimated

— per share

Actual

Expected May 18, After Hours